Jeff Yass’s TScan Therapeutics TCRX Stock Holding History
Bought
Maintained
Sold
Other funds holding TCRX
LCM
BBA
DF
Jeff Yass's TCRX Position: Q3 2026 in Review
Jeff Yass sold out of TScan Therapeutics (TCRX) in Q3 2026, closing a stake of 23,623 shares — an estimated $23.2K sold.
Jeff Yass first reported a position in TCRX in Q3 2023 and held it in 11 quarters. The position peaked at $2.37M in Q1 2024. 52 funds tracked by Wall St. Rank hold TCRX as of Q3 2026.
- Jeff Yass reported no remaining TScan Therapeutics position as of Q3 2026 after selling out during the quarter.
- Jeff Yass sold 23,623 TScan Therapeutics shares in Q3 2026, an estimated $23.2K.
- Jeff Yass first reported a position in TScan Therapeutics in Q3 2023 and held it in 11 quarters.
- Jeff Yass's TScan Therapeutics position peaked at $2.37M in Q1 2024.
- 52 funds tracked by Wall St. Rank held TScan Therapeutics as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.